IndiaInfoline » Markets » NATCOPHARM

Natco Pharma Ltd - Share Price

NATCOPHARM

Open

910.10

Prev. Close

908.70

Turnover (lac.)

1,797

Day's High

936.95

Day's Low

908.00

52 Week's High

996.00

52 Week's Low

402.55

Book Value

223

Face Value

2

Mkt Cap (Cr.)

16,973

P/E

41.17

EPS

22.08

Divi. Yield

0.74

Natco Pharma LtdFinancials

Switch to
Consolidated
Standalone

Loading ...

Natco Pharma LtdNews & Updates

Meeting Type

Meeting Date

Resolution Type Description Of Resolution IiAS Recommendation

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd546.5545.38130,763.76724.810.733,207.24106.10
Divis Laboratories Ltd3,672.6554.9696,627.91513.300.441,713.78313.47
Dr Reddys Laboratories Ltd4,871.5032.8480,637.51481.000.523,333.60979.45
Cipla Ltd760.2027.2661,140.71745.640.533,711.03233.61
Aurobindo Pharma Ltd893.0019.5852,092.87801.540.344,425.43246.88

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

Natco Pharma LtdSummary & Reports

No Company Summary found

Registered Office

Natco House,Road No 2 Banjara Hills,Hyderabad, Telangana,500033

Tell. : +91-040-23547532
Website : http://www.natcopharma.co.in
Email : investors@natcopharma.co.in

Registrar Office

12-10-167, Bharath Nagar, Hyderbad - 500018 INDIA

Tell. : +91-040-23818475/76/2
Website : www.vccilindia.com
Email : info@vccilindia.com

View

- <

Reco. Price

Nov 13,2020 11:23 AM

Target Price

Target Returns:

0.00%

Result Express

Natco Pharma Ltd's Q2FY19 consolidated net profit rises 115.17% yoy to Rs181.60cr : Misses Estimates

Dec 03, 2020 12:51 PM

The company’s consolidated revenue stood at Rs543.50cr, up 27.37% yoy and 0.91% qoq.

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Dividend

    Annc. Date

    12 Nov 2020

    Effective. Date

    24 Nov 2020

    Divi. Type

    Interim 2

    Divi.(%)

    150

    Divi. Amt.

    3

    Unaudited Financial Results for the Quarter and Half year ended 30th September, 2020... More

  • Purpose

    Board Meeting

    Exp. Date

    12 Nov 2020

    Annc. Date

    03 Nov 2020

    NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is sched... More

  • Purpose

    AGM

    Exp. Date

    15 Oct 2020

    Annc. Date

    18 Sep 2020

    AGM 15/10/2020Notice of 37th Annual General Meeting for the financial year 2019-20Paper notice publi... More